216 related articles for article (PubMed ID: 14529686)
1. [18F]fluorodeoxyglucose positron emission tomography as a useful indicator of metastatic gestational trophoblastic tumor: preliminary results in three patients.
Sironi S; Picchio M; Mangili G; Garavaglia E; Zangheri B; Messa C; Voci C; Taccagni GL; del Maschio A; Fazio F
Gynecol Oncol; 2003 Oct; 91(1):226-30. PubMed ID: 14529686
[TBL] [Abstract][Full Text] [Related]
2. The role of 18F-fluorodeoxyglucose positron emission tomography in gestational trophoblastic tumours: a pilot study.
Chang TC; Yen TC; Li YT; Wu YC; Chang YC; Ng KK; Jung SM; Wu TI; Lai CH
Eur J Nucl Med Mol Imaging; 2006 Feb; 33(2):156-63. PubMed ID: 16220307
[TBL] [Abstract][Full Text] [Related]
3. Role of 18F-FDG PET in the management of gestational trophoblastic neoplasia.
Mapelli P; Mangili G; Picchio M; Gentile C; Rabaiotti E; Giorgione V; Spinapolice EG; Gianolli L; Messa C; Candiani M
Eur J Nucl Med Mol Imaging; 2013 Apr; 40(4):505-13. PubMed ID: 23314259
[TBL] [Abstract][Full Text] [Related]
4. Imaging of Metastatic Epithelioid Trophoblastic Tumor With 18F-FDG PET/CT.
Patel T; Oldan J
Clin Nucl Med; 2018 Jun; 43(6):e200-e202. PubMed ID: 29659388
[TBL] [Abstract][Full Text] [Related]
5. Dual-tracer PET/CT imaging in evaluation of metastatic hepatocellular carcinoma.
Ho CL; Chen S; Yeung DW; Cheng TK
J Nucl Med; 2007 Jun; 48(6):902-9. PubMed ID: 17504862
[TBL] [Abstract][Full Text] [Related]
6. [F-18]fluorodeoxyglucose positron emission tomography and positron emission tomography: computed tomography in recurrent and metastatic cholangiocarcinoma.
Jadvar H; Henderson RW; Conti PS
J Comput Assist Tomogr; 2007; 31(2):223-8. PubMed ID: 17414758
[TBL] [Abstract][Full Text] [Related]
7. Usefulness 18F-FDG positron emission tomography/computed tomography for detecting recurrence of hepatocellular carcinoma in posttransplant patients.
Kim YK; Lee KW; Cho SY; Han SS; Kim SH; Kim SK; Park SJ
Liver Transpl; 2010 Jun; 16(6):767-72. PubMed ID: 20517911
[TBL] [Abstract][Full Text] [Related]
8. Whole-body
Gajjala SR; Hulikal N; Kadiyala S; Kottu R; Kalawat T
Indian J Med Res; 2018 Mar; 147(3):256-262. PubMed ID: 29923514
[TBL] [Abstract][Full Text] [Related]
9. Primary epithelioid trophoblastic tumor with a synchronous breast carcinoma detected only with FDG-PET/CT Scan.
Kara T; Ozcan Kara P; Baba F; Celik C; Kara Gedik G
Rev Esp Med Nucl; 2011; 30(6):368-71. PubMed ID: 21440960
[TBL] [Abstract][Full Text] [Related]
10. Value of FDG PET in papillary thyroid carcinoma with negative 131I whole-body scan.
Chung JK; So Y; Lee JS; Choi CW; Lim SM; Lee DS; Hong SW; Youn YK; Lee MC; Cho BY
J Nucl Med; 1999 Jun; 40(6):986-92. PubMed ID: 10452315
[TBL] [Abstract][Full Text] [Related]
11. 18F-FDG PET/CT for the prediction and detection of local recurrence after radiofrequency ablation of malignant lung lesions.
Singnurkar A; Solomon SB; Gönen M; Larson SM; Schöder H
J Nucl Med; 2010 Dec; 51(12):1833-40. PubMed ID: 21078787
[TBL] [Abstract][Full Text] [Related]
12. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
13. Metastasis detection with 18 FDG-positron emission tomography/computed tomography in gestational trophoblastic neoplasia: a report of 2 cases.
Cortés-Charry R; Figueira LM; Nieves L; Colmenter L
J Reprod Med; 2006 Nov; 51(11):897-901. PubMed ID: 17165437
[TBL] [Abstract][Full Text] [Related]
14. Discordant findings in patients with non-small-cell lung cancer: absolutely normal bone scans versus disseminated bone metastases on positron-emission tomography/computed tomography.
Ak I; Sivrikoz MC; Entok E; Vardareli E
Eur J Cardiothorac Surg; 2010 Apr; 37(4):792-6. PubMed ID: 20015657
[TBL] [Abstract][Full Text] [Related]
15. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K
Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
[TBL] [Abstract][Full Text] [Related]
16. Role of
Lopez-Lopez V; Robles R; Brusadin R; López Conesa A; Torres J; Perez Flores D; Navarro JL; Gil PJ; Parrilla P
Br J Radiol; 2018 Jan; 91(1081):20170216. PubMed ID: 29034693
[TBL] [Abstract][Full Text] [Related]
17. Comparative Performance of ¹⁸F-FDG PET/MRI and ¹⁸F-FDG PET/CT in Detection and Characterization of Pulmonary Lesions in 121 Oncologic Patients.
Sawicki LM; Grueneisen J; Buchbender C; Schaarschmidt BM; Gomez B; Ruhlmann V; Wetter A; Umutlu L; Antoch G; Heusch P
J Nucl Med; 2016 Apr; 57(4):582-6. PubMed ID: 26742715
[TBL] [Abstract][Full Text] [Related]
18. FDG-PET for detection of pulmonary metastases from malignant primary bone tumors: comparison with spiral CT.
Franzius C; Daldrup-Link HE; Sciuk J; Rummeny EJ; Bielack S; Jürgens H; Schober O
Ann Oncol; 2001 Apr; 12(4):479-86. PubMed ID: 11398879
[TBL] [Abstract][Full Text] [Related]
19. 18F-fluorodeoxyglucose positron emission tomography in small-cell lung cancer.
Zhao DS; Valdivia AY; Li Y; Blaufox MD
Semin Nucl Med; 2002 Oct; 32(4):272-5. PubMed ID: 12524651
[TBL] [Abstract][Full Text] [Related]
20. The sensitivity of 18F-fluorodeoxyglucose positron emission tomography in the evaluation of metastatic pulmonary nodules.
Fortes DL; Allen MS; Lowe VJ; Shen KR; Wigle DA; Cassivi SD; Nichols FC; Deschamps C
Eur J Cardiothorac Surg; 2008 Dec; 34(6):1223-7. PubMed ID: 18848459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
